Yep, without the cuvettes things get very difficult, more so for measuring molar concentration than drug ID.
Drug ID in containers using Raman spectroscopy is quite common.
Simutaneouly using Raman spectroscopy and fluoresences also creates interference issues since the Raman signal is relatively weak compared to the fluorescent signal. That could be a problem if that's what they're trying to do.
With the cuvettes, it allowed UV/IR absorption measurements which can determine molar concentration. That is how I suspect the older Valimeds worked, but you can't do that without a cuvette.
I believe that there's other issues with the drug containers too, some of which are just beginning to come to light.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.